- Home
- ADCT vs SHIP Comparison
ADCT vs SHIP Comparison
Compare ADCT & SHIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADCT
- SHIP
- Stock Information
- Founded
- ADCT 2011
- SHIP 2008
- Country
- ADCT Switzerland
- SHIP Greece
- Employees
- ADCT N/A
- SHIP N/A
- Industry
- ADCT Biotechnology: Pharmaceutical Preparations
- SHIP Marine Transportation
- Sector
- ADCT Health Care
- SHIP Consumer Discretionary
- Exchange
- ADCT Nasdaq
- SHIP Nasdaq
- Market Cap
- ADCT 143.1M
- SHIP N/A
- IPO Year
- ADCT 2020
- SHIP 2007
- Fundamental
- Price
- ADCT $1.49
- SHIP $6.64
- Analyst Decision
- ADCT Strong Buy
- SHIP Strong Buy
- Analyst Count
- ADCT 5
- SHIP 2
- Target Price
- ADCT $8.50
- SHIP $12.00
- AVG Volume (30 Days)
- ADCT 344.2K
- SHIP 219.7K
- Earning Date
- ADCT 03-27-2025
- SHIP 03-06-2025
- Dividend Yield
- ADCT N/A
- SHIP 11.45%
- EPS Growth
- ADCT N/A
- SHIP 1658.44
- EPS
- ADCT N/A
- SHIP 2.11
- Revenue
- ADCT $70,837,000.00
- SHIP $167,459,000.00
- Revenue This Year
- ADCT $6.81
- SHIP N/A
- Revenue Next Year
- ADCT $11.24
- SHIP $10.86
- P/E Ratio
- ADCT N/A
- SHIP $3.23
- Revenue Growth
- ADCT 1.84
- SHIP 51.91
- 52 Week Low
- ADCT $1.39
- SHIP $6.55
- 52 Week High
- ADCT $5.38
- SHIP $13.19
- Technical
- Relative Strength Index (RSI)
- ADCT 39.46
- SHIP 35.40
- Support Level
- ADCT $1.41
- SHIP $7.00
- Resistance Level
- ADCT $1.68
- SHIP $7.53
- Average True Range (ATR)
- ADCT 0.12
- SHIP 0.24
- MACD
- ADCT -0.03
- SHIP -0.06
- Stochastic Oscillator
- ADCT 16.00
- SHIP 5.22
About ADCT ADC Therapeutics SA
ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.